SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640334-19-002671
Filing Date
2019-12-24
Accepted
2019-12-23 20:56:04
Documents
79
Reference 429
333-234673

Document Format Files

Seq Description Document Type Size
1 POS AM embi_posam.htm POS AM 1847749
2 EX-23.1 embi_ex231.htm EX-23.1 1577
9 embi_posamimg1.jpg GRAPHIC 9487
  Complete submission text file 0001640334-19-002671.txt   9690057

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT embi-20190930.xml EX-101.INS 2174158
4 XBRL TAXONOMY EXTENSION SCHEMA embi-20190930.xsd EX-101.SCH 81788
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE embi-20190930_cal.xml EX-101.CAL 38992
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE embi-20190930_def.xml EX-101.DEF 462776
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE embi-20190930_lab.xml EX-101.LAB 643036
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE embi-20190930_pre.xml EX-101.PRE 563509
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-231951 | Film No.: 191307906
SIC: 2834 Pharmaceutical Preparations